Otsuka Holdings Co., Ltd. (FRA:OS1)
Germany
· Delayed Price · Currency is EUR 46.40
+4.00 (9.43%)
At close: May 2, 2025, 10:00 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Pharmaceuticals | 1,629.03B |
Log In |
Log In |
Log In |
Log In |
| Pharmaceuticals Growth | 17.10% |
Log In |
Log In |
Log In |
Log In |
| Nutraceuticals | 557.01B |
Log In |
Log In |
Log In |
Log In |
| Nutraceuticals Growth | 15.24% |
Log In |
Log In |
Log In |
Log In |
| Consumer Products | 33.75B |
Log In |
Log In |
Log In |
Log In |
| Consumer Products Growth | -8.94% |
Log In |
Log In |
Log In |
Log In |
| Other Segment | 110.07B |
Log In |
Log In |
Log In |
Log In |
| Other Segment Growth | 2.85% |
Log In |
Log In |
Log In |
Log In |
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Pharmaceuticals Segment Profit | 285.11B |
Log In |
Log In |
Log In |
Log In |
| Pharmaceuticals Segment Profit Growth | 98.47% |
Log In |
Log In |
Log In |
Log In |
| Nutraceuticals Segment Profit | 59.78B |
Log In |
Log In |
Log In |
Log In |
| Nutraceuticals Segment Profit Growth | 74.56% |
Log In |
Log In |
Log In |
Log In |
| Consumer Products Segment Profit | 23.00B |
Log In |
Log In |
Log In |
Log In |
| Consumer Products Segment Profit Growth | 89.50% |
Log In |
Log In |
Log In |
Log In |
| Other Segment Profit | 7.53B |
Log In |
Log In |
Log In |
Log In |
| Other Segment Profit Growth | 2606.83% |
Log In |
Log In |
Log In |
Log In |
| Eliminations from Segment Profit | -51.85B |
Log In |
Log In |
Log In |
Log In |
| Eliminations from Segment Profit Growth | 2.26% |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Japan | 699.70B |
Log In |
Log In |
Log In |
Log In |
| Japan Growth | 4.29% |
Log In |
Log In |
Log In |
Log In |
| North America | 1,095.10B |
Log In |
Log In |
Log In |
Log In |
| North America Growth | 25.38% |
Log In |
Log In |
Log In |
Log In |
| Overseas | 1,630.20B |
Log In |
Log In |
Log In |
Log In |
| Overseas Growth | 20.96% |
Log In |
Log In |
Log In |
Log In |
| Europe | 242.90B |
Log In |
Log In |
Log In |
Log In |
| Europe Growth | 11.07% |
Log In |
Log In |
Log In |
Log In |
| Others | 292.20B |
Log In |
Log In |
Log In |
Log In |
| Others Growth | 14.27% |
Log In |
Log In |
Log In |
Log In |
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Pharmaceuticals Business Profit | 390.61B |
Log In |
Log In |
Log In |
Log In |
| Pharmaceuticals Business Profit Growth | 32.97% |
Log In |
Log In |
Log In |
Log In |
| Nutraceuticals Business Profit | 64.15B |
Log In |
Log In |
Log In |
Log In |
| Nutraceuticals Business Profit Growth | -46.90% |
Log In |
Log In |
Log In |
Log In |
| Consumer Products Business Profit | 23.66B |
Log In |
Log In |
Log In |
Log In |
| Consumer Products Business Profit Growth | -38.27% |
Log In |
Log In |
Log In |
Log In |
| Other Segment Business Profit | 6.95B |
Log In |
Log In |
Log In |
Log In |
| Other Segment Business Profit Growth | -137.77% |
Log In |
Log In |
Log In |
Log In |
| Eliminations from Business Profit | -54.91B |
Log In |
Log In |
Log In |
Log In |
| Eliminations from Business Profit Growth | 12.80% |
Log In |
Log In |
Log In |
Log In |